Cannabinoid receptor 2 antagonists are potent inhibitors of bone resorption in vitro and ovariectomy-induced bone loss in vivo

被引：0
|
作者：
不详
机构：
来源：
CALCIFIED TISSUE INTERNATIONAL | 2006年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] CANNABINOID RECEPTOR ANTAGONISTS INHIBIT OSTEOCLASTIC BONE RESORPTION IN VITRO AND PREVENT OVARIECTOMY INDUCED BONE LOSS IN VIVO
    Idris, A. I.
    Van't Hof, R. J.
    Greig, I. R.
    Ridge, S. A.
    Ross, R. A.
    Ralston, S. H.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S34 - S34
  • [2] Cannabinoid receptor antagonists inhibit osteoclastic bone resorption in vitro and prevent ovariectomy induced bone loss in vivo
    Idris, AI
    van't Hof, RJ
    Greig, IR
    Ridge, SA
    Ross, RA
    Ralston, SH
    BONE, 2004, 34 : S22 - S22
  • [3] Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo
    Sun, Peng
    Yang, Qichang
    Wang, Yanben
    Peng, Jiaxuan
    Zhao, Kangxian
    Jia, Yewei
    Zhang, Tan
    Lu, Xuanyuan
    Han, Weiqi
    Qian, Yu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 4189 - 4203
  • [4] Rosuvastatin inhibits bone resorption in vitro by inhibiting protein prenylation, and prevents ovariectomy-induced bone loss in vivo
    Hughes, A
    Crockett, JC
    Idris, AI
    van't Hof, RJ
    Rogers, MJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S260 - S260
  • [5] Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor
    Idris, Aymen I.
    Sophocleous, Antonia
    Landao-Bassonga, Euphemie
    van't Hof, Robert J.
    Ralston, Stuart H.
    ENDOCRINOLOGY, 2008, 149 (11) : 5619 - 5626
  • [6] Cannabinoid receptor antagonists inhibit osteoclast formation in vitro and ovariectomy-induced bone loss in vivo through the CB1 and CB2 receptors
    Sophocleous, A.
    Landao-Bassonga, E.
    van't Hof, R.
    Ralston, S. H.
    Idris, A. I.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S31 - S31
  • [7] Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen nitroxybutylester (HCT1026)
    Armour, KJ
    van't Hof, RJ
    Armour, KE
    Torbergsen, AC
    Del Soldato, P
    Ralston, SH
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : 2185 - 2192
  • [8] Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss
    Li, J. X.
    Liu, J.
    He, C. C.
    Yu, Z. Y.
    Du, Y.
    Kadota, S.
    Seto, H.
    MATURITAS, 2007, 58 (01) : 59 - 69
  • [9] The Type 2 Cannabinoid Receptor Regulates Bone Mass and Ovariectomy-Induced Bone Loss by Affecting Osteoblast Differentiation and Bone Formation
    Sophocleous, Antonia
    Landao-Bassonga, Euphemie
    van't Hof, Robert J.
    Idris, Aymen I.
    Ralston, Stuart H.
    ENDOCRINOLOGY, 2011, 152 (06) : 2141 - 2149
  • [10] Cannabinoid receptor 1 knockout mice have increased bone mass and are protected from ovariectomy-induced bone loss
    Idris, AI
    Van't Hof, RJ
    Greig, IR
    Ridge, SA
    Baker, D
    Ross, RA
    Ralston, SH
    BONE, 2005, 36 : S132 - S132
12345